1. Home
  2. Universitat de Barcelona
  3. Química Inorgànica i Orgànica
  4. View Item

The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Author

de la Torre, Beatriz G.

Albericio Palomera, Fernando

Publication date

2020-05-06T15:36:26Z

2020-05-06T15:36:26Z

2018-02-27

2020-05-06T15:36:26Z

Share

Abstract

This is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 Biologics) approved by the FDA during 2017. The drugs included in the 2017 "harvest" have been classified on the basis of their chemical structure: biologics (antibodies and proteins); peptides; amino acids and natural products; drug combinations; and small molecules.

Document Type

Article

Published version

Language

English

Subjects and keywords

Disseny de medicaments; Pèptids; Farmacologia; Drug design; Peptides; Pharmacology

Publisher

MDPI

Related items

Reproducció del document publicat a: https://doi.org/10.3390/molecules23030533

Molecules, 2018, vol. 23, num. 3, p. 533

https://doi.org/10.3390/molecules23030533

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

cc-by (c) de la Torre, Beatriz G. et al., 2018

http://creativecommons.org/licenses/by/3.0/es

This item appears in the following Collection(s)

ISGlobal - Institut de Salut Global de Barcelona [61351]

Química Inorgànica i Orgànica [1016]